Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema ; volume:21 ; number:1 ; day:30 ; month:6 ; year:2020 ; pages:1-8 ; date:12.2020
Respiratory research ; 21, Heft 1 (30.6.2020), 1-8, 12.2020
- Urheber
-
Zantah, Massa
Dotan, Yaniv
Dass, Chandra
Zhao, Hauqing
Marchetti, Nathaniel
Criner, Gerard J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-020-01432-x
- URN
-
urn:nbn:de:101:1-2020082919535253585939
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zantah, Massa
- Dotan, Yaniv
- Dass, Chandra
- Zhao, Hauqing
- Marchetti, Nathaniel
- Criner, Gerard J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
Mechanisms and management of COPD exacerbations
Interferon therapy for preventing COPD exacerbations
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
WNT/Frizzled signaling in COPD and emphysema
How do COPD patients respond to exacerbations?
Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection
Relevance of human metapneumovirus in exacerbations of COPD
Accelerated extracellular matrix turnover during exacerbations of COPD
Optimizing bronchodilation in the prevention of COPD exacerbations
Renaming COPD exacerbations: the UK respiratory nursing perspective
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
Mechanisms and management of COPD exacerbations
Interferon therapy for preventing COPD exacerbations
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
WNT/Frizzled signaling in COPD and emphysema
How do COPD patients respond to exacerbations?
Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection
Relevance of human metapneumovirus in exacerbations of COPD
Accelerated extracellular matrix turnover during exacerbations of COPD
Optimizing bronchodilation in the prevention of COPD exacerbations
Renaming COPD exacerbations: the UK respiratory nursing perspective
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
Mechanisms and management of COPD exacerbations
Interferon therapy for preventing COPD exacerbations
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
WNT/Frizzled signaling in COPD and emphysema
How do COPD patients respond to exacerbations?
Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection
Relevance of human metapneumovirus in exacerbations of COPD
Accelerated extracellular matrix turnover during exacerbations of COPD
Optimizing bronchodilation in the prevention of COPD exacerbations
Renaming COPD exacerbations: the UK respiratory nursing perspective